Literature DB >> 3495806

A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells.

D J FitzGerald, M C Willingham, C O Cardarelli, H Hamada, T Tsuruo, M M Gottesman, I Pastan.   

Abstract

One form of multidrug resistance is due to the expression of a 170-kDa energy-dependent drug efflux pump called P-glycoprotein in the plasma membranes of human cancer cells. We have prepared conjugates of Pseudomonas toxin with the anti-P-glycoprotein monoclonal antibody MRK-16. These anti-P-glycoprotein-toxin conjugates specifically kill multidrug-resistant human KB cells. Similar conjugates could be useful in cancer therapy to reduce or eliminate multidrug-resistant tumor populations in tumors intrinsically resistant to chemotherapy or in populations that become resistant during combination chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495806      PMCID: PMC305070          DOI: 10.1073/pnas.84.12.4288

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  25 in total

1.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

Authors:  K Ueda; C Cardarelli; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins.

Authors:  D W Shen; C Cardarelli; J Hwang; M Cornwell; N Richert; S Ishii; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

3.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

4.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

5.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs.

Authors:  S Akiyama; A Fojo; J A Hanover; I Pastan; M M Gottesman
Journal:  Somat Cell Mol Genet       Date:  1985-03

6.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

7.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

8.  Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.

Authors:  M M Cornwell; M M Gottesman; I H Pastan
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

9.  Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus.

Authors:  D J FitzGerald; I S Trowbridge; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 12.779

10.  Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.

Authors:  D J FitzGerald; T A Waldmann; M C Willingham; I Pastan
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 19.456

View more
  29 in total

Review 1.  Genetic aspects of multidrug resistance.

Authors:  M Pauly; F Ries; M Dicato
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

Review 2.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells.

Authors:  S Yemul; C Berger; M Katz; A Estabrook; R Edelson; H Bayley
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 4.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

5.  Conformational effects of amino acid substitutions in the P-glycoprotein of the mdr 1 gene.

Authors:  P W Brandt-Rauf; G Lee; R P Carty; M R Pincus; J M Chen
Journal:  J Protein Chem       Date:  1989-08

6.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.

Authors:  O Seemann; M Muscheck; M Siegsmund; H Pilch; C T Nebe; J Rassweiler; P Alken
Journal:  Urol Res       Date:  1995

8.  Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells.

Authors:  W Van de Vrie; S A Van der Heyden; E E Gheuens; A M Bijma; E A De Bruijn; R L Marquet; A T Van Oosterom; A M Eggermont
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

9.  Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.

Authors:  E B Mechetner; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 10.  Antibody-directed therapy of multidrug-resistant tumor cells.

Authors:  T Efferth; M Volm
Journal:  Med Oncol Tumor Pharmacother       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.